Seizert Capital Partners, LLC Jazz Pharmaceuticals PLC Transaction History

Seizert Capital Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$150.19 - $173.5 $7.24 Million - $8.36 Million	-48,182 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$140.71 - $165.05 $667,950 - $783,492	-4,747 Reduced 8.97%	48,182 $7.95 Million
Q3 2020 Nov 03, 2020	SELL	$105.46 - $144.13 $1.34 Million - $1.83 Million	-12,719 Reduced 19.37%	52,929 $7.55 Million
Q2 2020 Aug 06, 2020	SELL	$95.68 - $121.88 $832,511 - $1.06 Million	-8,701 Reduced 11.7%	65,648 $7.24 Million
Q1 2020 May 05, 2020	SELL	$87.74 - $152.74 $979,529 - $1.71 Million	-11,164 Reduced 13.06%	74,349 $7.42 Million
Q4 2019 Feb 10, 2020	SELL	$117.65 - $153.73 $1.67 Million - $2.18 Million	-14,186 Reduced 14.23%	85,513 $12.8 Million
Q3 2019 Nov 07, 2019	SELL	$125.18 - $143.24 $193,528 - $221,449	-1,546 Reduced 1.53%	99,699 $12.8 Million
Q2 2019 Aug 06, 2019	BUY	$125.55 - $144.48 $12.7 Million - $14.6 Million	101,245 New	101,245 $14.4 Million

514

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.